Background: Whether parental drinking and smoking during pregnancy are associated with an increased risk of cancer in offspring is controversial. There are some indications that maternal alcohol consumption is associated with an elevated risk of acute myeloid leukemia (AML) appearing in very young children. Evidence for an association between maternal smoking during pregnancy and risk of leukemia in offspring has been inconsistent. Purpose: Using data from a Childrens Cancer Group case-control study, we evaluated relationships between infant leukemia risk and parental alcohol consumption and/or cigarette smoking during pregnancy or during the month prior to it. Methods: Three hundred two leukemia cases (203 acute lymphoid leukemias [ALLs], 88 AMLs, and 11 other leukemia types) diagnosed in children at 18 months of age or younger and 558 individually matched, regional (i.e., same telephone area code and exchange number) controls were included in the analysis. Information concerning parental alcohol consumption and smoking behavior during the index pregnancy and during the month prior to it was collected by telephone interviews with the mothers of all case and control subjects and the fathers of 250 case and 361 control subjects. Odds ratios (ORs) were used to measure the risk of infant leukemia associated with parental smoking and drinking; tests for trend were used to assess dose-response relationships. The data were analyzed further after stratifying the leukemia cases according to histologic and morphologic types. Reported P values are from two-sided tests of statistical significance. Results: Maternal drinking during pregnancy (compared with not drinking) was associated with ORs of 1.43 (95% confidence interval [CI] = 1.00-2.04) for ALL and 2.64 (95% CI = 1J6-5.06) for AML. A dose-response relationship was observed for total maternal alcohol consumption during pregnancy and risk of AML (P<.01). Alcohol-related risk appeared to be most pronounced for children who developed AML with a morphology of Ml (myeloblastic with minimal maturation) or M2 (myeloblastic with maturation) (OR = 7.62; 95% CI = 2.03-28.64). Paternal alcohol consumption did not confer an increased risk of infant leukemia. Maternal smoking during pregnancy (compared with not smoking) was negatively associated with infant leukemia risk (OR = 0.66 and 95% CI = 0.46-0.94 for total leukemia; OR = 0.45 and 95% CI = 0.21-0.96 for AML), whereas paternal smoking 1 month prior to pregnancy (compared with not smoking during the same period) was
Cigarette smoke contains many well-known carcinogens, such as nitrosamines, benzene, and radioactive compounds (/-3) . In some epidemiologic studies (4) (5) (6) , maternal smoking during pregnancy has been reported to be associated with cancer, particularly leukemia, in offspring. The evidence, however, is inconsistent . Lack of quantitative information, recall bias, and inability to control for passive smoking might account for some of the inconsistencies.
Alcohol drinking is a behavior that often accompanies cigarette smoking. Although alcohol consumption during pregnancy has been linked to fetal growth retardation and miscarriage (12) (13) (14) , its role in the etiology of childhood cancer has not been well studied. Studies examining children aged 0-15 years have generally found no association between maternal alcohol consumption during pregnancy and risk of childhood leukemia (15, 16) . A study by the Childrens Cancer Group (CCG) (7), however, suggested that maternal alcohol consumption during pregnancy was associated with an elevated risk of acute myeloid leukemia (AML), particularly myelomonocytic and monocytic leukemia, among children under the age of 3 years. The Dutch Childhood Leukemia Study Group (17) subsequently reported 1.8-fold and 2.0-fold elevations in risk of acute nonlymphocytic leukemia among children aged 0-4 years and 5-9 years, respectively, linked to maternal alcohol consumption during pregnan-cy. Although based on small sample sizes, these findings indicate that childhood age and histologic type of disease are important parameters in assessing associations between preconceptional and in utero exposures and the risk of childhood leukemia.
Leukemia occurring in the first year of life is now well recognized as a biologically distinct entity. Infant leukemia cases, compared with cases in older age groups, differ in morphology (18) , clinical manifestation (18) , and cytogenetic and molecular findings (19, 20) . For example, abnormalities involving chromosome Ilq23, where the MLL gene (a gene associated with human leukemias) is located, are seen almost exclusively in infant leukemia cases (19) .
In this study, we have evaluated relationships between the risk of infant leukemia and parental cigarette smoking and alcohol consumption. We used data from a case-control study that was designed to investigate the effects of several preconceptional and in utero exposures on the development of leukemia among children aged 18 months or younger. We have reported the findings of our analysis of parental preconceptional x-ray exposure and risk of infant leukemia previously (21) . Relationships between other factors and infant leukemia risk will be evaluated in future reports.
Subjects and Methods
The case group in this study consisted of children who were 18 months of age or younger and were newly diagnosed with leukemia between January 1, 1983, and December 31, 1988. Cases were identified through the registration files of the CCG, a cooperative clinical trials group with approximately 100 member and affiliated institutions in the United States, Canada, and Australia. To be eligible for the study, there had to be a telephone in the patient's residence, and the patient's biological mother had to speak English and be available for an interview. A total of 492 cases were identified during the study period, and 382 met the eligibility criteria. Telephone interviews with mothers were completed for 302 case subjects (79.1%). The remaining 80 case subjects were not interviewed because of physician refusal (n = 19), parental refusal (n = 30), loss to follow-up after initial contact (n = 18), or other miscellaneous reasons (n = 13), such as a lack of institutional review board approval at a local institution and delays in scheduling interviews prior to the completion date of the study.
Each participating institution of the CCG was required to review the initial diagnostic bone marrow of case subjects according to the French-AmericanBritish (FAB) classification system and to submit the histopathologic and morphologic data to the CCG registry. Centralized review for diagnostic clarification was conducted for all cases, and the results were used in this study. Of the 302 case subjects included, 203 were diagnosed with acute lymphoid leukemia (ALL) and 88 with AML. The remaining 11 were diagnosed with other leukemia types. For the AML cases, 43.2% were FAB Ml (myeloblastic with minimal maturation) or M2 (myeloblastic with maturation); 17% were M4 (myelomonocytic), 35.2% were M5 (monocytic), and 4.6% were others.
Control subjects were randomly selected by use of a previously described random-digit-dialing procedure (22) and were individually matched to case subjects in a 2 to 1 ratio by year of birth and telephone area code and exchange number. As for the case subjects, there had to be a telephone in the control subject's residence, and the biological mother had to speak English and be available for an interview. A total of 743 eligible control subjects were identified. Of these, the mothers of 558 (75.1%) children were interviewed, which resulted in 50 sets of 1:1, 249 sets of 1:2, two sets of 1:3, and one set of 1:4 case:control matching sets. The major reason for nonparticipation of control subjects was parental refusal (18.6%).
With the use of structured questionnaires, data were collected by independent telephone interviews with mothers as well as with fathers (if available) of case and control subjects. The mother's questionnaire included questions about demographics, events and exposures prior to and during the index pregnancy and birth, lifetime occupational history, reproductive history, and family medical history. The father's questionnaire focused on medication use, x-ray exposure, personal habits prior to the index pregnancy, lifetime occupational history, and family medical history. The father's questionnaires were completed for 280 (73%) of the 382 eligible case subjects and 511 (69%) of the 743 eligible control subjects. Of these totals, direct interviews with fathers were obtained for 89% of case subjects and 71 % of control subjects. The remaining interviews were completed by mothers as surrogates for the fathers.
Detailed information regarding parental tobacco smoking and drinking habits was obtained. Parents were asked whether they had ever smoked or drank in their lifetime or whether they smoked or drank at the time of interview, 1 month prior to or during each trimester of the index pregnancy, or during the nursing period. Respondents who reported smoking or drinking a month before or during pregnancy were asked about the amount of smoking and the type and frequency of alcohol consumption.
One 4-ounce glass of wine, one 12-ounce can of beer, or 1 ounce of liquor, each of which contains approximately 0.5 ounce of absolute alcohol, was defined as one drink. An index of cumulative intake of total alcohol was computed by summing the products of frequency of wine, beer, and liquor intake multiplied by total weeks of gestation.
Data were analyzed by use of a conditional logistic regression model. Odds ratios (ORs) were used to measure the risk of infant leukemia associated with parental smoking and drinking behaviors. The number of cigarettes smoked was categorized as 0, 1-10, 11-20, and more than 20 cigarettes per day. The frequency of wine, beer, and liquor consumption was grouped into 0, 1-4 drinks per month, and more than 4 drinks per month. These cut points were chosen to conform to those used in previous epidemiologic studies (5, 6, 1223 ) of cancer and pregnancy outcome. The estimated total alcohol consumption during pregnancy was categorized as 0, 1-20 drinks, and more than 20 drinks, so that the results could be compared with those of the previous CCG study (7) . Trend tests were performed by treating the categorical variables as continuous in the model. Reported probability values are based on two-sided tests of statistical significance.
Results
Of the 302 evaluated infant leukemia patients, 91 (30%) were younger than 7 months at diagnosis, 96 (32%) were 7-12 months old, and 115 (38%) were 13-18 months old. There were more girls than boys (female/male = 1.16) among the case group, but there were more boys than girls (female/male = 0.77) among the control group.
Mothers of case patients were significantly younger than mothers of control subjects at the birth of the index child (mean age was 26.7 years for mothers of case patients and 27.5 years for mothers of control subjects; P = .02), but the test for linear trend in risk of infant leukemia by maternal age category was not statistically significant. Mothers of case patients had an overall lower education level and, perhaps, lower income than mothers of control subjects (Table 1) . Fathers of case patients tended to be less educated and younger at the time of birth of the index child than fathers of control subjects, although most differences were not statistically significant.
Forty percent of mothers of case patients (120 of 302) versus 31% of mothers of control subjects (173 of 558) reported ever drinking during pregnancy with the index child, resulting in an OR for leukemia of 1.60 (95% confidence interval [CI] = 1.18-2.18) ( Table 2 ). The association appeared to be more pronounced for AML (OR = 2.64; 95% CI = 1.36-5.06). The elevated risk of AML was associated with alcohol consumption at each trimester of pregnancy, but the risk tended to be higher for drinking that occurred later in the pregnancy. Alcohol consumption during the month prior to pregnancy was related to a marginally significant risk of AML, but drinking during the nursing period was not associated with risk of AML. Maternal alcohol consumption during pregnancy was associated with only a moderately increased risk of ALL (OR = 1.43; 95% CI = 1.00-2.04). The risk of ALL, however, was not significantly related to trimester-specific alcohol consumption. Maternal drinking a month prior to pregnancy or during the nursing period was not related to the risk of ALL. Given that alcohol consumption during different time frames in the perinatal period was associated with leukemia risk, we examined the patterns of alcohol consumption in an effort to determine whether there was a critical period in which the fetus was most sensitive to alcohol. With the group who never drank during the month prior to and during pregnancy as the referent, a 2.28-fold (95% CI = 1.26-4.13) elevated risk of ALL and a 10.48-fold (95% CI = 2.79-39.33) elevated risk of AML were observed to be associated with maternal drinking during the second and/or third trimester (Table 2 ). Drinking throughout pregnancy was associated with a nonsignificantly elevated risk of AML (OR = 2.26; 95% CI = 0.89-5.74). Risk of ALL and AML remained moderately elevated, although not significantly, when the mother quit drinking prior to pregnancy or prior to the second trimester.
The risk of infant leukemia was further examined by the type and amount of alcohol consumed by the mother during the index •ALL = acute lymphoid leukemia; AML = acute myeloid leukemia; OR = odds ratio; CI = confidence interval. Subjects with missing values were excluded. tAdjusted for sex, maternal age, education, and maternal smoking during pregnancy. Compared with women who did not drink during the indicated period. §Compared with women who did not drink during the month prior to pregnancy and throughout pregnancy.
pregnancy (Table 3) . The association between maternal alcohol consumption and infant leukemia varied little with age at diagnosis (1-6 months, 7-12 months, and 13-18 months) and was not altered after adjustment for birth weight or paternal preconceptional x-ray exposure, risk factors in the study population (27) .
In general, the risk of infant leukemia was negatively associated with maternal cigarette smoking ( Table 4 ). The risk of leukemia of all types was 31%-38% lower for infants whose mothers smoked during pregnancy. No clear dose-response relationship was found between the number of cigarettes smoked by the mother and risk of infant leukemia, although the risk appeared slightly lower for offspring of heavy smokers. Decreased risk was observed for both ALL and AML and appeared not to vary substantially with the trimester in which smoking occurred. Adjustment for birth weight or maternal marijuana use and paternal x-ray exposure did not alter the association.
Relationships between infant leukemia risk and paternal alcohol consumption, smoking 1 month prior to pregnancy, and smoking during pregnancy were examined (Table 5) . One hundred ninety-nine (74.3%) of 268 fathers of case patients and 352 (70.3%) of 501 fathers of control subjects drank during the month prior to the index pregnancy; however, the difference between these groups diminished after adjustment for maternal alcohol drinking. Neither the type nor the amount of alcohol consumed by fathers was related to the risk of infant leukemia. Paternal smoking in the month prior to the index pregnancy (OR = 1.56; 95% CI = 1.03-2.36) or during the index pregnancy (OR = 1.45; 95% CI = 0.95-2.19) was related to a slightly elevated risk of ALL. The risk of ALL, however, did not appear to increase with the number of cigarettes smoked by fathers during the month prior to pregnancy or during pregnancy. Paternal smoking was related to a nonsignificantly decreased risk of AML. Given that a considerable proportion of fathers' questionnaires were completed by proxy respondents, we performed additional analyses restricted to subjects with direct interviews. We did not observe appreciable changes in the risk estimates of alcohol consumption and cigarette smoking. No interaction was found between maternal and paternal alcohol consumption and smoking. •ALL = acute lymphoid leukemia; AML = acute myeloid leukemia; OR = odds ratio; CI = confidence interval. Subjects with missing values were excluded. tAdjusted for sex, maternal age, education, and maternal alcohol consumption during pregnancy. }Compared with women who did not smoke during the indicated period. *ALL = acute lymphoid leukemia; AML = acute myeloid leukemia; OR = odds ratio; CI = confidence interval. Subjects with missing values were excluded. tAdjusted for sex, paternal age, education, and maternal alcohol consumption during pregnancy. }Compared with men who did not drink during the indicated period. §Compared with men who did not smoke during the indicated period.
Discussion
Consistent with the results of the previous CCG study (7) and a Dutch study (7 7), we found that maternal alcohol consumption during pregnancy was associated with an increased risk of AML among infants. The risk of AML appeared to increase with the frequency of maternal drinking, was pronounced for children whose mothers drank during the second or third trimester of pregnancy, and was associated with all types of alcohol. Maternal alcohol consumption during the second or third trimester of pregnancy was also associated with risk of ALL. Paternal alcohol consumption immediately preceding the index pregnancy was not related to risk of either ALL or AML.
The information from this study regarding alcohol consumption is dependent on the recall of the participants. In general, the lack of an association between paternal drinking and risk of leukemia argues against recall bias as the sole explanation for our findings. Moreover, the overall rate of 31% for drinking during pregnancy by mothers of control subjects is in good agreement with the findings from a recent study of a cohort of middle-class pregnant women (i.e., 32%) (25) . There might, however, be misclassification of the amount and timing of alcohol consumption. One could speculate that mothers of case patients may tend to underreport the amount or duration of alcohol consumption during pregnancy. If such misclassification did occur, it could explain why drinking throughout pregnancy was not associated with the highest risk and why increased drinking beyond 8 drinks per month did not further increase the risk of leukemia, although the latter risk estimate was based on a small number of subjects. Alternatively, one could also speculate that these observations might be due to a possible association between heavy alcohol consumption and miscarriage (12, 13) , with the selective abortion of fetuses susceptible to leukemia. However, no biological basis for such selection has been established.
It is unclear why the alcohol effect is predominant in AML, particularly AML with M1/M2 morphology. It is well recognized, however, that ALL and AML have different geographic distributions, with AML being more common in Asia and developing countries and ALL being the predominant type of childhood leukemia in western countries (24) . Previously, we reported from the current study population that paternal preconceptional x-ray exposure was related to increased risk of ALL but not of AML (21) . These observations, together with the findings of the current analysis, suggest that the etiology of AML and ALL or their subtypes might be different. The finding that the alcohol association is more pronounced in AML of M1/M2 morphology is inconsistent with the finding from the previous CCG study (7) , which indicated that the association between maternal alcohol consumption and risk of AML was predominantly for AML with M4/M5 morphology. These morphologically specific associations, however, were based on a small sample size and need to be further evaluated in a larger scale study.
Although the nature of the association between alcohol consumption and leukemia is not clear, a number of possible mechanisms have been suggested. Ethanol can activate microsomal enzymes that are involved in precarcinogen metabolism in a variety of tissues. In some animal tissues, ethanol's effect on microsomal cytochrome P450 activity may result in increased levels of electrophilic metabolites of precarcinogens that are not readily detoxified (25) (26) (27) . If similar enzyme activation occurs in humans, we would expect that alcohol consumption later in pregnancy might have a greater effect because both maternal and fetal enzymes could be involved at that time (28, 29) . The influence of fetal enzymes early in pregnancy would be expected to be minimal because the producing organs may not be well developed.
Other mechanisms might also be involved. In vitro studies have demonstrated that ethanol can inhibit antigen-specific Tlymphocyte proliferation (50) and depress phagocytosis by monocytes and macrophages (57), both of which could affect immune function. An in vitro study (32) using HL60 cells (myeloid precursor cells) demonstrated that ethanol can cause growth arrest in the presence of differentiation-promoting agents, resulting in cells partially differentiated along the myeloid line and not fully competent. Since clusters of blood stem cells appear in early life (33) , it is possible that alcohol consumption in pregnancy could adversely affect myeloid cell differentiation. Additional in vitro studies may help clarify the effect of alcohol on terminal differentiation in the myeloid pathway.
Evidence regarding maternal smoking during pregnancy and risk of leukemia in offspring is equivocal. An elevated risk of leukemia among children under the age of 15 years has been reported to be associated with maternal smoking during pregnancy (4) (5) (6) . Other studies, however, have failed to confirm this association (7-77) or have found an inverse but not statistically significant association (77). In the current study, we found that maternal smoking was negatively associated with the risk of both ALL and AML among infants. For this study, we obtained copies of prenatal and delivery medical records for 754 (87.7%) of the 860 participants (details to be reported elsewhere.) For these 754 subjects, information on smoking status during pregnancy was recorded in the medical charts of 534 (70.8%). There was 92.5% concordance between interview data and the medical charts regarding maternal smoking during pregnancy. Therefore, recall bias seems unlikely to be the explanation for the negative association. We adjusted for maternal education to minimize potential confounding from socioeconomic status; however, residual bias may still exist, since adjusting for maternal education alone will not completely control for social class. Heavy smoking during pregnancy has been linked to low birth weight and miscarriage (14^23J4). Adjusting for birth weight, however, did not change the relationship between leukemia risk and maternal smoking. We would expect a deficiency of leukemia cases among infants of smoking women only if leukemia-prone fetuses were more susceptible to the effect of smoking than were normal fetuses. Once again, no biological basis for such selection has been established.
The association between paternal smoking and leukemia risk in offspring is also controversial (5, 7, 35) . We found that a slightly elevated risk of ALL was associated with paternal smoking 1 month prior to pregnancy. The risk, however, did not appear to be related to the amount of smoking. Certainly, more studies are needed to better understand the effect of parental smoking on infant leukemia risk.
In summary, this study suggests that maternal alcohol consumption is related to an elevated risk of AML among infants. No evidence indicates that maternal smoking during pregnancy is related to an increased risk of infant leukemia. Future studies should focus on the evaluation of the effect of timing of alcohol consumption, morphology-specific associations, and interaction between alcohol consumption and other environmental exposures. Studies of biologic mechanisms for alcohol exposure during pregnancy and infant leukemia are also warranted. 
